The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow COO
The Cooper Companies, Inc. (COO) Operating cash flow
The Cooper Companies, Inc.'s operating cash flow for fiscal 2025 was $796.1M, up 12.2% from $709.3M in fiscal 2024. Over the twelve months to 31 July 2026 it was $1.0B. Over the past ten years it has ranged from $390.9M (fiscal 2015) to $796.1M (fiscal 2025) — the current reading is the highest in ten years. The Cooper Companies, Inc. ranks 7th of 54 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $796.1M | 12.24% |
| FY2024 | $709.3M | 16.76% |
| FY2023 | $607.5M | (12.26%) |
| FY2022 | $692.4M | (6.26%) |
| FY2021 | $738.6M | 51.79% |
| FY2020 | $486.6M | (31.77%) |
| FY2019 | $713.2M | 6.62% |
| FY2018 | $668.9M | 12.69% |
| FY2017 | $593.6M | 16.48% |
| FY2016 | $509.6M | 30.37% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jul 2026 | $341.7M | 86.93% |
| Apr 2026 | $182.8M | (29.93%) |
| Jan 2026 | $260.9M | 5.24% |
| Oct 2025 | $247.9M | (5.16%) |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BAX Baxter International Inc. compare | $1.3B |
| COO The Cooper Companies, Inc. | $1.0B |
| ALGN Align Technology, Inc. compare | $755.7M |
| AVTR Avantor, Inc. compare | $597.0M |
| ATR AptarGroup, Inc. compare | $583.5M |
| BLCO Bausch + Lomb Corporation compare | $458.0M |
| TFX Teleflex Incorporated compare | $244.5M |
| SOLV Solventum Corporation compare | $209.0M |
| RGEN Repligen Corporation compare | $134.9M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on COO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement